Sensei Biotherapeutics, Inc. (SNSE) — DEF 14A Filings
All DEF 14A filings from Sensei Biotherapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Sensei Biotherapeutics Files 2025 Proxy Statement
— Apr 11, 2025 Risk: low
Sensei Biotherapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 11, 2025, for its 2025 annual meeting of stockholders. The filing outlines -
Sensei Biotherapeutics Announces 2024 Annual Meeting of Stockholders
— Apr 29, 2024 Risk: low
Sensei Biotherapeutics, Inc. (SNSE) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. Annual Meeting scheduled for June 11, 2024, at 9:00 a.m. E
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX